<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35495863</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2589-790X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>4</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>CJC open</Title>
          <ISOAbbreviation>CJC Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Racial Differences in Delivery Outcomes Among Women With Peripartum Cardiomyopathy.</ArticleTitle>
        <Pagination>
          <StartPage>373</StartPage>
          <EndPage>377</EndPage>
          <MedlinePgn>373-377</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjco.2021.12.004</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Peripartum cardiomyopathy (PPCM) is a rare idiopathic cardiomyopathy associated with pregnancy that occurs more frequently among Black women. However, less is known about the association of race/ethnicity with outcomes at the time of delivery in women with PPCM.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We used data from the 2016-2018 National Inpatient Sample (NIS) database to identify women with a diagnosis of PPCM based on International Classification of Diseases, 10th revision (ICD-10) codes. Using adjusted logistic regression, the association of race with PPCM and adverse cardiovascular (CV) outcomes with PPCM was evaluated across racial/ethnic groups (White, Black, Hispanic, Asian/Pacific Islander).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 11,304,996 delivery hospitalizations, PPCM was present in 8735 (0.08%). After adjusting for CV risk factors (chronic hypertension, diabetes, and obesity) and socioeconomic factors (insurance status, hospital income, and residential income), Black and Native American women had greater adjusted odds of developing PPCM (adjusted odds ratio [aOR] 1.89; 95% confidence interval [CI] 1.66-2.15; aOR 1.60; 95% CI 1.02-2.50, respectively), compared with White women. In stratified analysis of CV events, however, Asian/Pacific Islander women with PPCM were the most likely to have CV complications (aOR 98; 95% CI 29-333 for pulmonary edema).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In the US, at the time of delivery hospitalization, Black and Native American women are the most likely to develop PPCM, despite adjustment for CV and socioeconomic risk factors, but Asian women have higher odds of having CV complications.</AbstractText>
          <CopyrightInformation>© 2021 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gambahaya</LastName>
            <ForeName>Ellise T</ForeName>
            <Initials>ET</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Minhas</LastName>
            <ForeName>Anum S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sharma</LastName>
            <ForeName>Garima</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vaught</LastName>
            <ForeName>Arthur J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adamo</LastName>
            <ForeName>Luigi</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zakaria</LastName>
            <ForeName>Sammy</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Michos</LastName>
            <ForeName>Erin D</ForeName>
            <Initials>ED</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hays</LastName>
            <ForeName>Allison G</ForeName>
            <Initials>AG</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>CJC Open</MedlineTA>
        <NlmUniqueID>101763635</NlmUniqueID>
        <ISSNLinking>2589-790X</ISSNLinking>
      </MedlineJournalInfo>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">La cardiomyopathie du péripartum (CMPP) est une rare cardiomyopathie idiopathique associée à la grossesse qui apparaît plus fréquemment chez les femmes noires. Toutefois, on en connaît peu sur l’association entre la race/l’origine ethnique et les issues au moment de l’accouchement chez les femmes atteintes d’une CMPP.</AbstractText>
        <AbstractText Label="MÉTHODES" NlmCategory="UNASSIGNED">Nous avons utilisé les données de la base de données de l’échantillon national des données de patients hospitalisés (NIS, de l’anglais <i>National Inpatient Sample</i>) de 2016-2018 pour trouver les femmes qui avaient un diagnostic de CMPP selon les codes de la Classification internationale des maladies, 10<sup>e</sup> révision (CIM-10). À l’aide de la régression logistique ajustée, nous avons évalué l’association de la race à la CMPP et les événements cardiovasculaires (CV) indésirables entre les groupes raciaux/ethniques (Blanches, Noires, Hispaniques, Asiatiques/îliennes du Pacifique).</AbstractText>
        <AbstractText Label="RÉSULTATS" NlmCategory="UNASSIGNED">Parmi les 11 304 996 hospitalisations liées à l’accouchement, on a noté la présence de la CMPP 8 735 (0,08 %) fois. Après l’ajustement des facteurs de risque CV (hypertension chronique, diabète et obésité) et des facteurs socioéconomiques (statut en matière d’assurances, indemnités journalières en cas d’hospitalisation et revenu familial), le risque relatif ajusté (RRa) des femmes noires et autochtones de manifester une CMPP était plus élevé (RRa 1,89; intervalle de confiance [IC] à 95 % 1,66-2,15; RRa 1,60; IC à 95 % 1,02-2,50, respectivement) que les femmes blanches. Toutefois, dans l’analyse stratifiée des événements CV, les femmes asiatiques et des îles du Pacifique qui avaient une CMPP étaient plus susceptibles d’avoir des complications CV (RRa 98; IC à 95 % 29-333 pour l’œdème pulmonaire).</AbstractText>
        <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Aux É.-U., lors des hospitalisations liées à l’accouchement, les femmes noires et autochtones sont les plus susceptibles de manifester une CMPP, en dépit de l’ajustement des facteurs de risque CV et des facteurs socioéconomiques, mais les femmes asiatiques ont un risque plus élevé d’avoir des complications CV.</AbstractText>
        <CopyrightInformation>© 2021 The Authors.</CopyrightInformation>
      </OtherAbstract>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35495863</ArticleId>
        <ArticleId IdType="pmc">PMC9039541</ArticleId>
        <ArticleId IdType="doi">10.1016/j.cjco.2021.12.004</ArticleId>
        <ArticleId IdType="pii">S2589-790X(21)00353-X</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Afana M., Brinjikji W., Kao D., et al.  Characteristics and in-hospital outcomes of peripartum cardiomyopathy diagnosed during delivery in the United States from the Nationwide Inpatient Sample (NIS) Database. J Card Fail. 2016;22:512–519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26923643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis M.B., Arany Z., McNamara D.M., Goland S., Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:207–221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31948651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gentry M.B., Dias J.K., Luis A., et al.  African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol. 2010;55:654–659.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3814012</ArticleId>
            <ArticleId IdType="pubmed">20170791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gunderson E.P., Croen L.A., Chiang V., et al.  Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011;118:583–591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21860287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolte D., Khera S., Aronow W.S., et al.  Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3</Citation>
        </Reference>
        <Reference>
          <Citation>Goland S., Modi K., Hatamizadeh P., Elkayam U. Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail. 2013;19:214–218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23582086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krishnamoorthy P., Garg J., Palaniswamy C., et al.  Epidemiology and outcomes of peripartum cardiomyopathy in the United States: findings from the Nationwide Inpatient Sample. J Cardiovasc Med (Hagerstown) 2016;17:756–761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25943626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agency for Healthcare Research and Quality  Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS) overview. www.hcup-us.ahrq.gov/nisoverview.jsp Available at:</Citation>
        </Reference>
        <Reference>
          <Citation>Irizarry O.C., Levine L.D., Lewey J., et al.  Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women. JAMA Cardiol. 2017;2:1256–1260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5815055</ArticleId>
            <ArticleId IdType="pubmed">29049825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ware J.S., Li J., Mazaika E., et al.  Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016;374:233–241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4797319</ArticleId>
            <ArticleId IdType="pubmed">26735901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Spaendonck-Zwarts K.Y., Posafalvi A., van den Berg M.P., et al.  Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J. 2014;35:2165–2173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24558114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goli R., Li J., Brandimarto J., et al.  Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation. 2021;143:1852–1862.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8113098</ArticleId>
            <ArticleId IdType="pubmed">33874732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain A., Norton N., Bruno K.A., et al.  Sex differences, genetic and environmental influences on dilated cardiomyopathy. J Clin Med. 2021;10:2289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8197492</ArticleId>
            <ArticleId IdType="pubmed">34070351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Minhas A.S., Ogunwole S.M., Vaught A.J., et al.  Racial disparities in cardiovascular complications with pregnancy-induced hypertension in the United States. Hypertension. 2021;78:480–488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8266726</ArticleId>
            <ArticleId IdType="pubmed">34098730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan SU, Yedlapati SH, Lone AN, et al. A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999-2018 [e-pub ahead of print]. Eur Heart J Qual Care Clin Outcomes https://doi.org/10.1093/ehjqcco/qcaa099, accessed December 1, 2021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ehjqcco/qcaa099</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
